News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
News Conference News TCT 2017 Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians Ashley Lyles November 06, 2017
News Opinion Editor's Corner TCT 2017 Live From Denver: TCT 2017, Day Three Shelley Wood November 01, 2017
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Opinion Fellow Talk My Picks for Fellows Attending TCT 2017 Amit K. Gupta, MBBS, MD October 26, 2017
News Daily News Long-term Evidence Supports Better Survival for Women Than Men After TAVR L.A. McKeown October 23, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Daily News Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria Caitlin E. Cox October 18, 2017
News Opinion Fellow Talk Why All Interventionalists Should Be on Twitter Amit K. Gupta, MBBS, MD October 18, 2017
News Daily News Some Reassurances, Some Sobering Truths About Dialysis Needs After TAVR Shelley Wood October 16, 2017
News Opinion Fellow Talk Be a HOT Interventionalist With Honest, Open, Two-Way Communication Kimberly Atianzar, MD October 11, 2017
News Daily News Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR Shelley Wood October 10, 2017
News Daily News Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues Caitlin E. Cox October 06, 2017